You just read:

aTyr Pharma Announces Issuance of US Patent That Extends Patent Protection of Physiocrines Derived From 20 out of 20 Human tRNA Synthetases

News provided by

aTyr Pharma, Inc.

Mar 15, 2017, 06:00 ET